North America Medical Robots Market

North America Medical Robots Market Size (2024 to 2029)

The Medical Robots Market size in North America is expected to reach USD 9.72 billion by 2029 from USD 3.92 billion in 2024, growing at a CAGR of 19.91%. The North American medical robot market is expected to account for the largest market share in the global market during the forecast period. This region is estimated to dominate the global market due to advancements in technology, growing acquisition of surgical robots by hospitals, and easy accessibility of upgraded medical robots in the market.

Medical Robots are the robots that are used in pharmaceutical sciences. These robots are of various types, including surgical robots and others. Medical robots assist in carrying out tasks with more precision than any unaided human surgeon or even provide the option of remote surgery in cases of unavailability of human surgeons.

Medical robots are the professional robots used in the hospital to improve the healthcare-related infrastructure & patient care. The North American medical robots market is forecasted to show evident potential in the mentioned period. The market continues to build momentum with the increase in technological advancements in pharma and healthcare. As a result, doctors can treat patients with ailments that a human surgeon can’t cure as effectively. Therefore, more and more companies have shown interest in this market recently.

The medical robot market of the North American region is majorly driven by technological advancements among medical robots and increasing the elderly population. Raising funds for research in robotic for medical by healthcare companies and growing patient importance for minimally invasive surgeries propel the growth in the medical robot market. Favorable government policies, high per capita income spent on healthcare, which the government makes, early diagnosis, and surgery for the diseases accelerating the medical field's robot market. The requirement of technical professionals during robotic surgery bolsters market growth.

The time required for regular approvals, an increase in the amount spent on research and development, the price associated with the robotics treatment, and the high cost of the devices is restraining the market demand. However, lack of awareness among the expert professionals, surgeons, and patients hampers this region's medical robot market growth.

This research report on the North American medical robot market has been segmented & sub-segmented into the following categories.

North America Medical Robots Market Analysis By Product

• Surgical Robots

  • Laparoscopy Robotic Systems

  • Orthopedic Robotic Systems

  • Neurosurgical Robotic Systems

  • Steerable Robotic Systems

• Rehabilitation Robotic Systems

  • Therapeutic Robotic Systems

  • Assistive Robotic Systems

  • Prosthetic Robotic Systems

  • Orthotic Robotic Systems

  • Exoskeleton Robotic Systems

• Non-Invasive Radiosurgery Robotic Systems

• Hospital And Pharmacy Robotic Systems

  • Pharmacy Robotic Systems

  • IV Robotic Systems

  • Telemedicine Robots

North America Medical Robots Market Analysis By Application

• Laparoscopy

• Orthopedics

• Neurology

• Special Education

North America Medical Robots Market Analysis By Country

• The United States

• Canada

• Rest of North America

Regional Analysis

In North America, the U.S. medical robots market is holding the most significant shares of the market. Da Vinci Surgical Systems received approval from USFDA for adult & pediatric robotic surgery. In 2018, the United States reported the 86% of the operations are performed with the help of robots. Due to the booming economy and the rise of several patients with neurological and cardiac diseases propelling the market's demand in the United States.

The U.S. is accounted to hold the largest share of the market in this region. The growing economy and increased number of patient populations diagnosed with neurological and cardiovascular diseases propel the U.S.'s market. According to the Association of American Medical College, the U.S. is likely to have a scarcity of approximately 90,000 doctors by the end of 2020 as the rehearsing doctors. They gain retirement by creating space for medical robots in hospitals and clinics. Moreover, 80% of radical prostatectomies are being performed using robotics in the U.S.

North America has the vast majority of the medical robot system in manufacturing & developing intelligent robots; some companies such as Medtronics, Stryker, and Mazor robotics companies are adding fuel to the North American medical robot market. In addition, U.S. & Canadian governments have increased funding to research projects for the hospital servicing robots. According to the American Cancer Society research in 2019, 42 % of the people are diagnosed with cancer, and they are treated with the non-invasive robotic radiosurgery procedure. Therefore, it can surge the U.S. market for medical robots. 

Recently, U.S.-based company Titan Medical signed an agreement with Medtronic. This new agreement developed single port robotics, said Titan Medical CEO, David McNally. 

The Canadian medical robots market is holding the second position in ruling the dominant shares of the market. Canada is known for being the world’s innovation hub in the medical robotics market for its facilities in the healthcare industry. The Canadian company, Kinova, collaborated with over 500 research firms to innovate medical robots for further growth in the market.  

KEY MARKET PLAYERS

Some of the major companies operating in the North American Medical Robots Market include Intuitive Surgical Inc., Hocoma AG, Hansen Medical Inc, Mazor Robotics Ltd, Accuray Incorporated, Arxium, Stryker Corporation, EKSO Bionics Holdings Inc., Omnicell Inc., and Kirby Lester LLC.